OpenArc Corporate Advisory »

Travere Therapeutics shares owned by OpenArc Corporate Advisory

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by OpenArc Corporate Advisory from 13F filings

Historical chart of OpenArc Corporate Advisory investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by OpenArc Corporate Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by OpenArc Corporate Advisory

Quarter filed Position value Share count Share price at filing
2026-03-31 $921k 31k 29.71

More positions owned by OpenArc Corporate Advisory

NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Grw Etf (IWF)
Blackrock Etf Trust Ishares A I Inno (BAI)
Tcw Transform Etf Trust Transform System (PWRD)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Ishares Tr Core Msci Eafe (IEFA)
Ab Active Etfs Emerging Mkts Op (EMOP)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Home Depot (HD)
Spdr Gold Tr Gold Shs (GLD)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
J P Morgan Exchange Traded F Active Value Etf (JAVA)
Ishares Tr Rus 1000 Val Etf (IWD)
Blackrock Etf Trust Ii Ishares Flexible (BINC)
Apple (AAPL)

View all positions for OpenArc Corporate Advisory

Top funds holding Travere Therapeutics

Henderson Group
FMR
BlackRock
Vanguard Group
Armistice Capital
State Street Corporation
Perceptive Advisors
Vanguard Capital Management
Nomura Asset Management International
Adage Capital Partners GP
Kynam Capital Management
Geode Capital Management
Renaissance Technologies
Stephens Investment Management Group
Goldman Sachs Group

View all funds holding Travere Therapeutics